Literature DB >> 6972224

Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.

M B Calderwood, J T Forbes, R T Smith.   

Abstract

Lymphoid cells stimulated by soluble tumour antigens in the MCA-induced murine fibrosarcoma system have been identified by subclass and protective capacity in adoptive syngeneic hosts. Lymph-node or spleen cells taken at weekly intervals after inoculation of syngeneic chemically induced fibrosarcomas were enriched by 3 methods in T, B, and "null" cell subclasses, and assayed for proliferative kinetics in response to soluble membrane antigens. The stimulated subpopulations were found to be heterogeneous, their composition varying with time and tumour burden. Initial proliferative responses after tumour inoculation were limited to the T-enriched subpopulation. Later during tumour growth, T, B and null cell fractions were vigorously and equally stimulated by tumour antigen. The ability of the same T, B or null-cell subpopulations to inhibit tumour growth was measured in adoptive hosts by a modified Winn assay. Only the T-cell subpopulation responding to tumour antigen in vitro effectively and consistently retarded tumour growth in vivo. In contrast to the shared specificities on syngeneic tumours identified by the proliferative assay, tumour-growth inhibition was limited to the specific tumour borne by the cell donor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972224      PMCID: PMC2010621          DOI: 10.1038/bjc.1981.73

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts.

Authors:  H J WINN
Journal:  J Immunol       Date:  1961-02       Impact factor: 5.422

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens.

Authors:  M S Meltzer; J J Oppenheim; B H Littman; E J Leonard; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.

Authors:  E S Golub
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

5.  Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.

Authors:  G M Mavligit; U Ambus; J U Gutterman; E M Hersh; C M McBride
Journal:  Nat New Biol       Date:  1973-06-06

6.  Cellular recognition by mouse lymphocytes in vitro. II. Specific stimulation by histocompatibility antigens in mixed cell culture.

Authors:  W H Adler; T Takiguchi; B Marsh; R T Smith
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

7.  The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.

Authors:  S Konda; Y Nakao; R T Smith
Journal:  Cancer Res       Date:  1973-10       Impact factor: 12.701

8.  Antigen solubilized from human leukemia: lymphocyte stimulation.

Authors:  J U Gutterman; G Mavligit; K B McCredie; G P Bodey; E J Freireich; E M Hersh
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

9.  Salt extraction of soluble HL-A antigens.

Authors:  R A Reisfeld; M A Pellegrino; B D Kahan
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

10.  Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens.

Authors:  W H Adler; T Takiguchi; B Marsh; R T Smith
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  1 in total

1.  Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.

Authors:  J Bubeník; P Perlmann; M Indrová; J Símová; T Jandlová; J Neuwirt
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.